Quick jump to page content
  • Main Navigation
  • Main Content
  • Sidebar
  • Register
  • Login
Trends in Pharmaceutical Biotechnology Trends in Pharmaceutical Biotechnology
  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Author
    • By Subject
    • Author Index
    • Keyword Index
  • Journal Info
    • About Journal
    • News
    • FAQ
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Publication Cycle-Process Flowchart
    • Peer Review Process
    • Indexing and Abstracting
    • Reviewers
    • APC fees
    • Journal Metrics
    • Related Links
  • Journal Policies
    • Advertising Policy
    • Informed consent policy
    • Artificial Intelligence policy
    • Authorship
    • Data Sharing Policy
    • Editorial Policies
    • Plagiarism Policy
    • Privacy Statement
    • Journal Funding Sources
    • Copyright and licensing
    • Self Archiving Policy
    • Ownership and Management
    • Allegations of Misconduct
    • Digital Archiving
    • Use of DOI
    • CrossMark Policy
    • Open Access Statement
    • Appeals & Complaints
    • Animal and ethical approve
    • Protection of Patients' Rights to Privacy
    • Ethical Approval for Studies Involving Human and Animal Participants
  • Guide for Authors
  • Guide for Reviewer
  • Submit Manuscript
  • Contact Us

About Journal

Trends in Pharmaceutical Biotechnology (TPB) is a peer-reviewed, open-access journal that was established in 2023 by Nabea Al-Ajyal Foundation Press. It is officially published by the Nabea Al-Ajyal Foundation for Sustainable Development and Education Improvement, a non-profit organization registered with the Government of Iraq (registration number: 1SE2409018). This foundation operates under the formal authorization and monitoring of the General Secretariat of the Iraqi Council of Ministers, the country's highest executive authority.

To submit a new manuscript, please start by reading the journal’s instructions for authors.

Search

Advanced filters

Search Results

Targeting Immune Checkpoints with Therapeutic Monoclonal Antibodies: Mechanisms and Therapeutic Advances

10.57238/tpb.2025.153196.1033
Dhulfiqar A. Abed (1), Shaimaa Obaid Hasson (2), Rawaa M. Mohammed (3), Noor Z. Kbah (4), Shimaa Mohamed Abu Zeid (5)
(1) Department of Pharmaceutical Chemistry, College of Pharmacy, Al Mustaqbal University, Hillah, Iraq ,
(2) Applied Biotechnology Department, College of Biotechnology, Al-Qasim Green University, Al-Qasim, Iraq ,
(3) Department of Basic and Medical Sciences, Nursing College, Al-Mustaqbal University, Hillah, Iraq ,
(4) Department of Pharmaceutics, College of Pharmacy, Al-Zahraa University for Women, 56001, Karbala, Iraq ,
(5) Department of Athletic Training and Movement Sciences, Faculty of Physical Education for Girls, Alexandria University, Alexandria, Egypt
28-47
PDF
Read Statistic: 373
1 - 1 of 1 items

makeSubmission

Sidebar menu

 Focus & scopes

 Manuscript template

 Publication Ethics

 Indexing

 Journal Metrics

Cover

Journal Cover

Publisher: Nabea Al-Ajyal Foundation Press 

Frequency: Semiannual

Print ISSN: 3005-7736

Online ISSN: 3005-7744

DOI Prefix: 10.57238/tpb

Iraqi National Library & Archives No. 2811 in 2025, Baghdad

EditorialTeam

Meet Our Editorial Team

Prof Dr. Ahmed AbdulJabbar Suleiman

Editor-in-Chief

University of Anbar, College of Science, Biotechnology Department.Iraq.

ORCID
Prof Dr. Yogesh Chandra Tripathi

Associate Editor-in-chief

Chemistry and Bioprospecting Division, Forest Research Institute, P.O. New
Forest, Dehradun-248006, India.

ORCID
Ass.Prof.Dr.Samet Poyraz

International Editorial Board

Department of Analytical Chemistry, Harran University Faculty of Pharmacy, Haliliye, Sanliurfa, Turkey.

ORCID
Read More
 

IndexedBy

   

CustomLink

Sites Link

Image 1      Image 2

              

Keywords

Most Viewed Articles
  • Monoclonal Antibodies in Modern Medicine: Their Therapeutic Potential and Future Directions
    288
  • Role of CRISPR-Cas Systems in the Pathogenesis of Periodontal Disease and Precision Periodontal Therapy
    193
  • Biochemical Application of New Synthetic Compounds of Pyridine Derivatives Incorporating on Tetrazole Moieties
    137
  • Development of Curcumin-Loaded Alginate Beads for Targeted Gastric Mucosa Delivery in Helicobacter Pylori-Associated Gastritis
    134
  • mRNA Vaccines Beyond COVID-19: Emerging Therapeutic Frontiers
    130

flaginfo

Flag Counter

  • Home
  • About Journal
  • Editorial Board
  • Submit Manuscript
  • Contact Us
  • Publication Ethics
  • Aims and Scope

News

               

CC BY 4.0 International License

Newsletter Subscription

Subscribe to the journal newsletter and receive the latest news and updates

© Nabea Al-Ajyal Foundation Press
Ver 1.4 : openjournaltheme.com
Themes by Openjournaltheme.com